chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DIZZINESS; FEELS LIKE GOING TO PASS OUT; LEG WEAKNESS; QUEASINESS; HEADACHE; NAUSEA; FEVER; CHILLS; LOSS OF APPETITE; This spontaneous report received from a parent concerned a 19 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid 19 positive test in November 2020. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 15:15 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced loss of appetite. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced dizziness. On 09-APR-2021, the subject experienced feels like going to pass out. On 09-APR-2021, the subject experienced leg weakness. On 09-APR-2021, the subject experienced queasiness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from loss of appetite, chills, nausea, fever, and headache on 08-APR-2021, and had not recovered from dizziness, leg weakness, queasiness, and feels like going to pass out. This report was non-serious.
Dose 1 given 2/4/2021 Moderna Lot # 016M20A, Patient died in the hospital from Covid 19
Became very fatigued, nauseous beginning around the 48 hours.  Nausea would come and go and has lasted over the course of the 60 hours proceeding the vaccine. I feel shaky and weak--which also comes and goes during the same time frame. Head feels "foggy".
This spontaneous report was received from a medical assistant and refers to multiple patients of unknown age an gender. No information regarding the patients' concurrent conditions, medical history and concomitant therapies was reported. On unknown dates, the patients received incorrectly stored doses of VAQTA (dose and route of administration were not reported) lot # reported as M037019, expiration date: 04-NOV-2018. No adverse effects were reported. The vaccines were stored in the temperature between 47 and 77 degrees Fahrenheit for 4 hours. Digital Data Logger was not involved. The vaccines underwent a previous temperature excursion for 45 minutes in the temperature between 47 and 77 degrees Fahrenheit. This is one of several reports received from the same reporter. Lot number M037019 is an invalid lot number for VAQTA. Additional information is not expected as there was no consent to contact the reporter.; Sender's Comments: US-009507513-1706USA000901:
low "motivation"; Chills; Headache; My throat was like irritation in throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: EW0167) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: APATHY (non-serious) with onset 11Aug2021, outcome "unknown", described as "low "motivation""; CHILLS (non-serious) with onset 11Aug2021, outcome "unknown", described as "Chills"; HEADACHE (non-serious) with onset 11Aug2021, outcome "unknown", described as "Headache"; THROAT IRRITATION (non-serious) with onset 11Aug2021, outcome "unknown", described as "My throat was like irritation in throat". Therapeutic measures were taken as a result of chills, headache, throat irritation.  Additional information: consumer stated, I am having some side effects from (Pfizer) Covid-19 Vaccine shot for 5 days it worsen and I came to the Doctor and Doctor told me to talk to you guys (Pfizer). It was reported by reporter "When probed for any treatment for the event, consumer stated, Today I took Tylenol 500 mg twice and some for my chills and then there was a spray they sprayed in my mouth, they gave couple of these, twice a day". Consumer stated, I was having a headache, chills, low motivation (not clarified) and in my throat was like irritation in throat. No Prior Vaccination within 4 weeks  No follow-up attempts are possible. No further information is expected.
" Moderna Covid-19 Vaccine EUA"  Headache and a rash with itchiness.
Patient presented to pharmacy to receive "2nd dose of Shingrix". After asking the patient of prior vaccination, she stated she, "had 1 previous Shingrix more than a couple months ago".  After vaccinating and logging in system, it was discovered that this was in fact her third vaccination of Shingrix. Dose logged in system appropriately and contacted physician.
Abdominal pain, transferred to ER 2/24/21, admitted to hospital, Expired at hospital 3/21/21
Child slumped over, unresponsive, stared blankly, lasted under 30 seconds/this happened two times after and then not since.
She had eaten breakfast prior to the immunizations.  Within minutes of receiving the vaccinations she became nauseated.  She began dry heaving.  she became pale.  She laid down and with verbal stimuli she would open her eyes but her eyes were rolled back.  she became diaphoretic.  After about 5-10 minutes she was more alert, opened her eyes and was responding verbally to questions.  She was then able to sit up, color returned to her face and nausea subsided.  After 15-20 minutes she was back to baseline and feeling fine, with the exception of pain at injection site.  There have been no further adverse effects noted.
Dysgeusia immediately following vaccine patient experienced change in taste . Patient also reports soreness at injection site which is mild . No shortness of breath , no facial droop ,no cardiovascular issues reported . Patient encouraged to be tested for COVID this week if symptoms persist.
RED MARKS ON BOTH LEGS REFERRED TO AS LINES ON LEGS, AFFECTED BOTH LEGS, FROM THE FRONT OF SHIN TO SIDE OF CALF/ STRIATION MARKS THAT ARE SLIGHTLY RED; FELT FUNNY, KIND OF SENSATION COMING FROM THE AREA; ITCHING; This spontaneous report received from a patient concerned a 63 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-APR-2021, the subject experienced itching. On 13-APR-2021, the subject experienced felt funny, kind of sensation coming from the area. On 14-APR-2021, the subject experienced red marks on both legs referred to as lines on legs, affected both legs, from the front of shin to side of calf/ striation marks that are slightly red. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red marks on both legs referred to as lines on legs, affected both legs, from the front of shin to side of calf/ striation marks that are slightly red, itching, and felt funny, kind of sensation coming from the area. This report was non-serious.
Urticarial rash in less < 8 hrs after administration of MMR, varicella & Hep A vaccines, responding to antihistamines. No other allergies hygiene identified.
Symptoms included dizziness, headache, body aches, nausea, vomiting,chills from 12/28/2020@1958 until 12/30/2020 Took Tylenol 1000mg x2
Pain in right arm, with muscle wasting.  Came to see Dr 10-9-2018 and was given a medrol pack that didn't help.  Came back to the office  12-17-2019 and referred to an Orthopedic for evaluation and treatment.
Hepatitis B vaccine administered 3/23/04, three days later developed severe rash on thighs, legs with urticaria. Treated with Clarinex, Atarax and Benadryl. Area treated with Lidex topical cream.
Left deltoid red/ swollen (DTaP) use wax in compress and take Motrin.
Pt recvd 1 dose of Engerix-B & w/in 24 hrs exp flu-like sx; recovered same day; sx reoccurred next day; pt indicated also exp chest involvement;
Brain fog; Extreme exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog) and FATIGUE (Extreme exhaustion) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included QUETIAPINE FUMARATE (SEROQUEL) for Sleep disorder NOS, VITAMINS NOS for an unknown indication.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Brain fog) and FATIGUE (Extreme exhaustion). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse drug reaction, at an unspecified dose and frequency; VITAMIN C [ASCORBIC ACID] for Adverse drug reaction, at an unspecified dose and frequency and ZINC for Adverse drug reaction, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Brain fog) and FATIGUE (Extreme exhaustion) had resolved.            The patient received booster dose and had extreme exhaustion and brain fog,  a state where she cannot really think fast and clear, which lasted about 10 days.   The patient said that the intensity remained the same, it has not worsened or improved over the past 10 days.  The patient drank lots of fluids and rested.  The patient concomitant medications also included supplements.  During the time of reporting, the patient stated that she haven't had the symptoms evaluated and seeing her primary care physician tomorrow.   This case was linked to MOD-2021-395717, MOD-2021-395928 (Patient Link).
Another dose was administered on opposite arm from first shot in both patients as indicated in; Needle came apart and two patients didn't received the full dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT COMPLAINT (Needle came apart and two patients didn't received the full dose.) and INCORRECT DOSE ADMINISTERED (Another dose was administered on opposite arm from first shot in both patients as indicated in) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced PRODUCT COMPLAINT (Needle came apart and two patients didn't received the full dose.). On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Another dose was administered on opposite arm from first shot in both patients as indicated in). At the time of the report, PRODUCT COMPLAINT (Needle came apart and two patients didn't received the full dose.) and INCORRECT DOSE ADMINISTERED (Another dose was administered on opposite arm from first shot in both patients as indicated in) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported No treatment medications were provided   This case was linked to US-MODERNATX, INC.-MOD-2021-089585 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089585:
Pounding on the ear; body pains in the leg and back; headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Pounding on the ear), MYALGIA (body pains in the leg and back) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included GLIMEPIRIDE, METFORMIN, ROSUVASTATIN, VITAMIN B12 NOS and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced TINNITUS (Pounding on the ear), MYALGIA (body pains in the leg and back) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 23-Mar-2021, TINNITUS (Pounding on the ear) and HEADACHE (headache) had resolved. At the time of the report, MYALGIA (body pains in the leg and back) had not resolved. Not Provided          Treatment medications included Tylenol in the beginning, then switched to taking Ibuprofen.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.
Tenderness, redness, streaking into the arm pit, no treatment, person that gave vaccination notified.
NO ADVERSE REACTION REPORTED. A PFIZER VACCINE WAS ADMISNISTERED TO A PATIENT AFTER BUD OF 7/22/22. PATIENT RECIEVED A PFIZER BOOSTER SHOT 5 DAYS AFTER BUD. The medical/safety team at Pfizer WAS CONTACTED AND indicated THE DISCOVERING PHARMACIST they do have stability but not efficacy data on the adult Pfizer vaccine beyond 72 days when stored in a refrigerator. They recommended that our rph contacts the CDC and inquires about repeating doses for these patients. Speaking with the CDC employees, our rph was given the same information as above and referred to the immunization division.  Our rph contacted the in the state, but she was asked to confer with either pharmacy's Medical Doctor or the standing order physician. Our rph was able to interact with the latter, and she was given the guidance of re-vaccinating . In the context of the guidance from the standing order physician, the patient will need to repeat the dose. Regular schedules for series completion/booster doses will be observed if/when warranted.
10/6 Local erythema, myalgia. 10/7 Subjective fever, worsening erythema & pain Rx ADVIL. 10/8 Worsening erythema & pain, temp 102. ADVIL, warm compress. 10/9 Improvement, decrease soreness & erythema. 10/21 all sx gone except small painful palpable mass at injection site.
Body aches, chills/feverish, headache, fatigue, arm soreness, a bit of nausea. Slept a ton. Felt 50% better by Wednesday late day, 95% better by Thursday am and could get up amc around and work again.
This spontaneous report as received from a nurse refers to unspecified patients of unknown age and gender. On an unknown dates the patients were vaccinated with improperly stored doses of GARDASIL (dose, route, lot numbers and expiration dates were not provided). No adverse events reported. This is one of several reports from the same source. Additional information has been requested.
Dr made by patient for PHN to observe site of FLUZONE injection(L) Deltoid- 2" from top - hematoma size of 25 cents-piece - black and blue on edge and white in the middle- welt on appearance,  the protrus then became inverted the next day. Tenderness at site. 11/2/08 - Flu vaccine, patient no area of redness, no pain. Still has bruise but is resolving.
Wrong lot number was placed on vaccine card and administration record.  Moderna was placed by mistake.  Patient's mother notified staff at clinic.  Unfortunatly unable to confirm that Pfizer was given.
Pt given immunizations and had syncopal episode. Pt then stiffened and began convulsing. Tonic clonic activity x approx 15 seconds. Pt then awakened. Mild confusion for a few minutes. Vital signs stable. Pt was referred to the ER and diagnosed with Vasovasal Syncope. Pt also has a neuro appointment on August 14th. Called mother and mother reports pt has had no further episodes.
Dizziness, Headache, Myalgia, Arthralgia,  NauseaVomiting, Injection site pain
significant hearing loss; This spontaneous case was reported by a patient and describes the occurrence of DEAFNESS (significant hearing loss) in a 77-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (1st Pfizer dose) on 28-Sep-2021 and PFIZER BIONTECH COVID-19 VACCINE (2nd Pfizer dose) on 09-Apr-2022. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. Concomitant products included ATORVASTATIN for an unknown indication.    On 24-Sep-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. In October 2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced DEAFNESS (significant hearing loss) (seriousness criterion medically significant). At the time of the report, DEAFNESS (significant hearing loss) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Caller explained approximately 2 weeks after getting Moderna vaccine he started noticing significant hearing loss and that was ongoing, it remained the same with no changes.  No treatment information was reported.  Company Comment: This is a spontaneous case concerning a 77 year-old, male patient with no reported medical history and concomitant use of atorvastatin, who experienced the serious (due to medically significant) unexpected, event of Deafness, which occurred approximately 2 weeks after the mRNA-1273.222 (Original/Omicron BA.4/5) vaccine, received as the first/second/third/booster/fourth dose of COVID-19 vaccination schedule. The outcome was reported as not recovered. Patient´s advanced age and concomitant use of atorvastatin remain as confounders. Patient received prior two doses of COVID-19 vaccine Tozinameran. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273 .222 (Original/Omicron BA.4/5) vaccine is not affected by this report.
Patient reports after receiving Influenza vaccine 12/18/14 started with low grade fever and body aches for over a week. Patient did not seek medical attention, just reported to CDC and PCP office.
p/waking from afternoon nap mom noticed red rash on lt neck & shoulder along w/fever of 101;APAP given & rash disappeared as fever went down;same event rash & fever, both resolved p/APAP;
Covid like symptoms. body aches, congestion, chest pain,   tested Positive for rhino Virus
10 minutes after vaccination, I was waiting in my car per instructions and began to feel extremely light headed and dizzy/faint.  I began to sweat a little and have minor tachycardia.  I never went back into the clinic but instead leaned the seat of my car back and those symptoms went away after about 30 minutes.  I never experienced any symptoms after that.
a patient developed facial nerve palsy after receiving gardasil; This spontaneous report was received from a consumer after GARDASIL vaccine administration", referring a 15-year-old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On an unspecified date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recombinant vaccine (GARDASIL) (strength, dose, frequency, route of administration, lot #, expiration date were not provided) as prophylaxis.   The abstract of the article stated that, on an unspecified date, after vaccine administration the patient developed peripheral facial nerve palsy. At the report time, the outcome of the event was unknown.  The causal relationship between the aforementioned event and the suspect vaccine was not provided.  Upon internal review, the event of peripheral facial nerve palsy was considered medically significant.
Hurts like son of a gun; Initial information received on 18-Sep-2021 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (non-health care professional).  This case involved an (unknown age and gender) patient who experienced hurts like son of a gun (pain) while receiving INFLUENZA VACCINE.  Past medical treatment(s), vaccination(s) concomitant medication and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date, the patient received in last weekend a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination   On an unknown date the patient developed a non-serious hurt like son of a gun (pain) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Pt was feeling light headed and dizzy. BP was 160/77 HR 61 02 sat 99% R/S RR 14 and blood glucose was 95. Pt was assisted to gurney to elevate feet and apple juice given as well as an ice pack for her posterior neck.  Pt began feeling better after juice given and BP was then 170/70 Hr58.  Pt was assisted in wheelchair to the car where her daughter drove her home.
RESIDENT BEGAN VOMITING AND BECAME UNRESPONSIVE AT 12PM.
2 weeks after my second dose of Moderna COVID vaccine I've started to develop a rash that will appear in different places all over my body. My neck, wrists, ankle and torso. The skin will get itchy then I will scratch it (lightly) and it will become very red and inflamed. It comes on quickly and also disappears quickly. I have gotten it on my face as well.  I spoke with my primary care doctor yesterday (about a week after this reaction began ). I sent her pictures. She is pretty certain this is caused by the vaccine and has prescribed Zyrtec 10 mg twice daily for 14 days. I've only taken 2 dose and I'm still getting the rash. The rash appears in no predictable way in terms of where it appears on the body.
Patient experienced outbreak of Shingles/Herpes Zoster 6 weeks after receiving Zostavax in V1 distribution
body aches; fatigue; headache; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site), MYALGIA (body aches), FATIGUE (fatigue) and HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 13-Feb-2021, the patient experienced MYALGIA (body aches), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site), MYALGIA (body aches), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.   Patient did not remember which arm she received the Moderna Covid-19 vaccine.  The treatment information was unknown.   This case was linked to MOD-2022-465328, MOD-2022-465346 (Patient Link).